MyFinsight
Home
Blog
About
Marketable securities
$400,660K
Cash and cash
equivalents
$96,599K
(-77.88%↓ Y/Y)
Prepaid expenses and
other assets
$6,561K
(-15.72%↓ Y/Y)
Total current assets
$503,820K
(13.37%↑ Y/Y)
Other assets
$6,910K
(0.99%↑ Y/Y)
Right of use asset
operating lease
$1,151K
(-48.55%↓ Y/Y)
Property and equipment,
net
$362K
(209.40%↑ Y/Y)
Total assets
$512,243K
(12.93%↑ Y/Y)
Total liabilities and
stockholders equity
$512,243K
(12.93%↑ Y/Y)
Total stockholders'
equity
$468,768K
(7.71%↑ Y/Y)
Total liabilities
$43,475K
(136.39%↑ Y/Y)
Accumulated deficit
-$470,613K
(-64.98%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$567K
Additional paid-in capital
$939,940K
(30.47%↑ Y/Y)
Total current
liabilities
$43,475K
(152.37%↑ Y/Y)
Common stock, 0.0001
par value,...
$8K
(14.29%↑ Y/Y)
Accrued expenses and
other current...
$33,666K
(180.55%↑ Y/Y)
Accounts
payable-Nonrelated Party
$7,431K
(264.09%↑ Y/Y)
Operating lease liability
current portion
$1,163K
(8.29%↑ Y/Y)
Accounts
payable-Related Party
$1,032K
(18.62%↑ Y/Y)
Accrued expenses and
other current...
$183K
(-85.27%↓ Y/Y)
Back
Back
Balance Sheet
Bicara Therapeutics Inc. (BCAX)
Bicara Therapeutics Inc. (BCAX)
source: myfinsight.com